TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
GOSS

Gossamer Bio Inc

Healthcare · Biotechnology

10.90$ +0.1% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement GOSS
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – – – -57.7%
– – – +940.1% +38.2% +21.1% -14.3% -1.0% -5.3% -75.9%
– – – – – – – – – -58.6%
– – +6,104.6% +159.4% +10.2% +7.8% +0.4% -20.8% +2.4% +25.7%
– +215.7% +16,713.4% -11.2% +27.1% -7.9% +4.0% -19.2% -6.0% +4.1%
– +1,289.2% +8,515.3% +83.8% +13.0% +4.8% +1.1% -15.9% -5.0% +20.7%
– – – – – – – – – –
– – -89.8% -100.0% – +53.5% -28.6% -2.7% -14.8% -4.6%
– – – – – – – – – –
– – – -74.9% +1,509.4% +83.3% -28.0% -7.8% -91.1% -109.9%
– – – – – – – – – –
– – – – – – – – – –

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?